Affiliation: University of Edinburgh

Dr. Arran Turnbull is a senior lecturer and group leader of the Translational Oncology Research Group at the Edinburgh Cancer Research Centre, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh. Arran's research focuses primarily on understanding, predicting and treating resistance to endocrine therapy and other therapeutics in breast cancer patients. Arran's undergraduate honours degree was in molecular biology at Heriot-Watt University. This was followed by a masters by research in immunology, genetics and pathway medicine at the University of Edinburgh. Arran graduated from his PhD in oncology at the University of Edinburgh in 2012 and took up a post-doctoral research position in the Edinburgh Breast Cancer Now Research Team before going on to form his own research group in 2017. Arran's PhD focused on the successful development and validation of a translational predictive test for endocrine therapy response in breast cancer for which he, the research team and the University of Edinburgh now hold the UK patent. This test has been successfully validated in several independent cohorts of patients and is moving towards a prospective clinical trial both in the UK and USA. Arran is also the principal investigator of research projects focused on DCIS, radiotherapy response and microwave radiometry for breast cancer diagnosis and prostate cancer.